ArticlePharmaceutics2026

Transferrin-Conjugated, Camptothecin-Bearing Dendrimersomes Entrapping Docetaxel as a Dual-Drug Nanoplatform for Targeted Prostate Cancer Therapy.

Musa Albatsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.